An Open Label Data Collection Study of My Connect Post-Op, a Post-Operative Communication Tool
Launched by CONCENTRA AI, INC · Aug 6, 2025
Trial Information
Current as of September 08, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new smartphone app called My Connect Post-Op, designed to help patients recover after joint replacement surgery (like knee or hip replacements). The app uses artificial intelligence to guide patients through their recovery by asking structured questions, spotting possible problems early, and offering helpful advice. The goal is to see how well the app supports patients during their healing process after surgery.
People who might join this study are adults aged 22 to 80 who are scheduled to have elective knee or hip replacement surgery and who own a smartphone. Participants need to speak and understand English and be able to give their consent to join. During the study, patients will use the app after their surgery, and researchers will collect information on how useful the app is in helping them recover. People with certain conditions, like psychiatric disorders or opioid dependence, or those currently in other clinical trials, may not be eligible. This study is currently looking for participants and aims to improve the way patients communicate and recover after joint replacement surgeries.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Orthopedic patients scheduled for elective joint arthroplasty (single or double knee, or single or double hip replacement surgery).
- • Age 22-80 years. Owns a smart phone. Speaks and understands written and spoken English. Ability to give written informed consent.
- Exclusion Criteria:
- • Known diagnosis of a psychiatric disorder. Known opioid dependence in the Investigator's opinion that may complicate participation.
- • Participation in another clinical trial investigating a drug, medical device, or a medical procedure in the 30 days preceding trial inclusion and throughout the duration of the trial.
- • Any condition that in the Investigator's opinion may complicate or preclude the subject from participating in this trial, such as physical impairment or noncooperation
About Concentra Ai, Inc
Concentra AI, Inc. is a clinical technology company specializing in the development and application of advanced artificial intelligence solutions to enhance clinical trial design, management, and data analysis. By leveraging cutting-edge AI and machine learning techniques, Concentra AI aims to improve the efficiency, accuracy, and predictive capabilities of clinical research, ultimately accelerating drug development and optimizing patient outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Wichita, Kansas, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported